Friday, July 10, 2026

Drug profile · INN

carbidopa,levodopa

carbidopa,levodopa (CARBIDOPA AND LEVODOPA) is an FDA-listed pharmaceutical active ingredient. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — carbidopa,levodopa
US status
approved
Class
Route
Patents
0
Programs
1
Data quality
0.81

Quick answer

carbidopa,levodopa (CARBIDOPA AND LEVODOPA) is an FDA-listed pharmaceutical active ingredient. Current US regulatory status: approved.

Key facts

INN carbidopa,levodopa
Brand CARBIDOPA AND LEVODOPA
Formulation CAPSULE, EXTENDED RELEASE

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. CELC200A2406 Approved · Novartis India · Parkinson's Disease

Frequently asked questions

What is carbidopa,levodopa?

carbidopa,levodopa (CARBIDOPA AND LEVODOPA) is an FDA-listed pharmaceutical active ingredient. Current US regulatory status: approved.

What is the brand name for carbidopa,levodopa?

CARBIDOPA AND LEVODOPA is a marketed brand name for carbidopa,levodopa. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of carbidopa,levodopa?

carbidopa,levodopa has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.